Abstract
(+)-Saxitoxin, a potent and reversible blocker of voltage-gated sodium channels, has attracted considerable interests as a scaffold for the development of novel analogs. Here, we report the design and synthesis of a tetracyclic analogue featuring an additional cis-fused five-membered ring (C5–C6), constructed via a novel photoinduced radical cycloaddition reaction. This transformation efficiently established the quaternary carbon center at C5, which is difficult to access by conventional methods. Although the IC50 values of two analogues against hNaV1.4 showed a significant decrease in potency, this work introduces a new chemotype of saxitoxin, offering a foundation for future optimization efforts.
Keywords: voltage-gated sodium channel, saxitoxin, photocycloaddition, radical cyclization, carbonyl hydration
Voltage-gated sodium channels (NaVs) belong to the cation channel family − and are widely distributed across neuronal, skeletal muscle, and cardiac muscle cell membranes. In humans, ten NaV isoforms (NaV1.1 to NaV1.9 and NaX) have been identified, each exhibiting distinct tissue distributions. Dysfunction of specific NaV subtypes is associated with severe diseases, such as epilepsy (NaV 1.1 and 1.2), periodic paralysis (NaV 1.4), and pain (NaV 1.7)conditions that affect millions of patients and impose substantial economic burdens annually. To address these disorders, the discovery of small-molecule inhibitors with high subtype selectivity has attracted considerable interest. However, currently available small-molecule NaV inhibitors, including clinical local analgesics (e.g., lidocaine, carbamazepine) and aryl/acyl sulfonamide derivatives (e.g., PF-05089771, GX-936), typically act as state- and frequency-dependent blockers, often accompanied by undesirable pharmaceutical properties such as high plasma protein binding and off-target activity. In contrast, naturally occurring NaV inhibitors like tetrodotoxin (TTX) exhibit state-independent channel blockade with remarkable selectivity. Structural modification of these natural toxins thus represents a promising strategy for developing potent and selective NaV inhibitors.
Saxitoxin (STX, 1a, Figure ), a paralytic shellfish toxin, is a potent inhibitor NaVs. Unlike TTX, STX demonstrates the ability to distinguish NaV1.7 from other isoforms, a selectivity largely attributable to the NaV1.7-specific two amino acid sequence motif in domain III (T1398/I1399), which reduces the IC50 of STX by 250-fold compared to isoforms such as NaV1.4. This unique feature has motivated considerable interest in modifying STX to elucidate its structure–activity relationships (SAR) and binding modes across NaV subtypes. Pioneering studies by the Du Bois and Nagasawa groups revealed that modifications at the C13 carbamate significantly influence NaV1.7 binding affinity, , with the ability to form a hydrogen bond being essential. Additionally, Du Bois and co-workers also shown that substitutions on the guanidine moiety substantially impair binding affinity. The efforts to modify the C11 and C13 positions of STX by both groups demonstrated that alterations at these sites modulate both binding affinity and isoform selectivity (e.g., 2 and 3). , In contrast, modifications at the C5 position remain unexplored, likely due to the inherent chemical inertness at this site. This sparks our curiosity to investigate how C5 modification would affect STX activity toward NaVs. Given that dicarbamoyl saxitoxin (dc-STX, 1b) retains potency comparable to STX (1a), we designed a tetracyclic analog, dc-tetracyclic STX 4, featuring a fused five-membered ring spanning C5–C6. This deep-seated structural modification was envisioned to conformationally constrain the C13 hydroxyl group into its bioactive orientation, potentially enhancing binding affinity.
1.
Saxitoxin, analogues, and the design of dc-tetracyclic STX.
Inspired by our prior total synthesis of STX (1a), we devised a retrosynthetic route to 4 via urea 5, involving guanidine installation and redox adjustments (Figure ). The additional five-membered ring fused across the C5–C6 bond was envisaged to arise from radical cyclization of hemiaminal 6, with an alkyne moiety serving as the radical acceptor. Conventional approaches for forging the C5 quaternary centersuch as alkylation of 7were deemed unfeasible due to prohibitive ring strain upon enolization (e.g., enolate 8). Instead, we proposed accessing 6 from 9, which could be derived from ozonolytic cleavage of the cycloheptene ring in compound 10 Z. The synthesis of 10 Z was planned via an intramolecular [5 + 2]-type cycloaddition between an 8-oxoxanthine and a vinylcyclopropane (VCP), leveraging the excited state of intermediate 11. In this strategic disconnection, the VCP unit served as a key synthon, enabling the formation of two adjacent quaternary centers at C4 and C5 in a single step. While metal-catalyzed [5 + 2] cycloadditions of VCPs with π-systems are well-established, intramolecular [5 + 2]-type cycloadditions initiated from the triplet-state of heterocycles remain rare, with only one precedent reported by You, Zheng, and co-workers.
2.
Retrosynthetic analysis of dc-tetracyclic STX (4).
Our synthesis commenced with the N 3-alkylation of 7-benzyl-8-bromoxanthine (12) using iodide 13, followed by sequential N 1-benzylation and hydrolytic cleavage of the C8–Br bond in a one-pot fashion (Scheme ). This afforded the photocycloaddition substrate 11 as a 1:1 mixture of inseparable Z/E olefin configurational isomers in 45% yield. Irradiation of 11 at 300 nm in toluene at room temperature promoted an intramolecular [2 + 2] cycloaddition, yielding product 14 as a 3.5:1 mixture of inseparable diastereomers in 70% yield (Table , entry 1). While DCM as solvent slowed the reaction but maintained a comparable yield of 14 (entry 2), acetone completely suppressed the transformation (entry 3). Notably, when xanthone was employed as a photosensitizer, we isolated 15 as the only identifiable product, which was unambiguously characterized by X-ray crystallography; full conversion was achieved using 0.5 equiv of xanthone, affording 15 in 48% isolated yield (entry 4). In contrast, substitution with benzophenone as the photosensitizer resulted in only a 10% yield of 15 (entry 5). Mechanistically, we propose that 11 underwent energy transfer to generate triplet-state A (Figure ), which then underwent a 5-exo radical cyclization followed by cyclopropane ring opening to form biradical intermediate B. Following intersystem crossing (ISC) to the singlet state, ring-closing radical–radical recombination would furnish either 10 E or 10 Z, though the formation of 10 E might be disfavored due to the strained E-olefin geometry in a seven-membered ring. Nonetheless, subsequent hydrogen atom abstraction of 10 by exited-state xanthone could generate allylic radical C, enabling alkene migration and ultimately producing 15. Further mechanistic studies are warranted to validate this hypothesis.
1. Total Synthesis of Anhydro-dc-Tetracyclic Saxitoxin (26) .
a Reagents and conditions: (a) 13, K2CO3, DMF, rt, 15 h then BnBr, K2CO3, DMF, rt, 8 h then KOH, EtOH/H2O, 95 °C, 18 h, 45%. (b) Xanthone, DCM, 302 nm, rt, 24 h, 48%. (c) O3, MeOH, −78 °C, 20 min, then FeSO4·7H2O, TEMPO, rt, 2 h, 35%. (d) DIBAL, DCM, −78 °C, 30 min, 52%. (e) TBDPSCl, DCM, imdazole, 0 °C, 30 min, 72%. (f) mCPBA, DCM, 0 °C, 30 min, 81%. (g) Bestmann-Ohira reagent, K2CO3, MeOH, 0 °C to rt, 5 h, 85%. (h) LiBH4, THF/MeOH, 0 °C, 30 min, 88%. (i) Cp*TiCl3, TESCl, 4 Å MS, Zn, THF, 55 °C, 15 h, 72%. (j) O3, DCM, −95 °C then NaBH4, MeOH, 0 °C, 71% (21a/21b = 1:3). (k) MOMBr, TBAI, DCE, 60 °C, 2 h then TBAF, THF, rt, 30 min, 83%. (l) MsCl, NEt3, DCM, 0 °C, 2 h, quant. (m) DBU, NaI, DME, 100 °C, 18 h, 88%. (n) DTBBP, Li, THF, 0 °C, 2 h, 73%. (o) MeOTf, TTBP, DCM, rt, 24 h then EtCOONH4, NH3, MeOH, 65 °C, 36 h. (p) TFA, DCM, rt, 12 h, 54% (2 steps). (q) O3, MeOH, −95 °C, 10 min then Me2S, rt, 2 h, 87%. (r) O3, MeOH, −95 °C, 10 min then Me2S, rt, 2 h then TFA, DCM, rt, 12 h, 43% (2 steps). DIBAL, Diisobutylaluminum; TBAI, Tetrabutylammonium iodide; DTBBP, 4,4-di-tert-butylbiphenyl; TTBP, 2,4,6-tri-tert-butylpyrimidine.
1. Optimization of the Photocycloaddition.
Entry | Conditions | Yield |
---|---|---|
1 | toluene, 302 nm, rt, 12 h | 70% 14 |
2 | DCM, 302 nm, rt, 24 h | 68% 14 |
3 | acetone, 302 nm, rt, 12 h | NR |
4 | 0.5 equiv xanthone, 302 nm, DCM, rt, 10 h | 48% 15 |
5 | 0.5 equiv Ph2CO, 302 nm, DCM, rt, 10 h | 10% 15 |
[11] = 0.01 M (10 mg).
Isolated yield after flash chromatography. NR = no reaction.
3.
Proposed mechanism for the formation of 15.
The intramolecular [5 + 2]-type photocycloaddition reaction of 11 proceeded smoothly on a 500 mg scale to afford 15. We next investigated the oxodealkenylative cleavage of the seven-membered carbocycle in 15 via ozonolysis, followed by treatment with ferrous sulfate and TEMPO. Interestingly, the only isolable product was compound 16, which was obtained in a moderate 35% yield. The outcome suggested that, contrary to the typical preference for formation of the more-stable radical species during C–C bond cleavage, a less-stable primary radical was generated and subsequently trapped by TEMPO. This unusual selectivity may be attributed to the electron-deficient nature of C12, which disfavored the formation of the secondary carbon radical to be captured by TEMPO (Figure S1; see DFT calculations in the Supporting Information). The methyl ester of 16 was then reduced with DIBAL and protected as the TBDPS ether to give 17. Oxidation of the TEMPO moiety to the corresponding aldehyde, followed by a Bestmann–Ohira reaction, furnished alkyne 18 in 69% yield over two steps. Subsequent reduction of the C6-carbonyl group with LiBH4 gave hemiaminal 19 in 88% yield. At this stage, the competing formation of a carbocation could potentially interfere with the desired homolytic C–O bond cleavage at C6. To address this, we employed Ti(III) as a single-electron reductant, which both coordinated to and weakened the C–O bond while simultaneously promoting radical formation. This Ti(III)-mediated radical cyclization proceeded smoothly to deliver tetracyclic intermediate 20 in 72% yield. Ozonolysis of 20 under −95 °C follow by NaBH4 reduction produced separable epimers 21a and 21b in 17% and 54% yield, respectively, whereas the major epimer 21b bore the desired stereogenic center at C13. Subsequent MOM protection of the C13-OH, in situ TBDPS deprotection, and elimination of the resulting primary alcohol via mesylation/DBU-NaI treatment afforded 22 in 73% yield over three steps; the structure of 22 was confirmed by X-ray crystallography analysis. The removal of benzyl groups was achieved using Li/DTBBP, furnishing 23 in 73% yield. Final-stage transformations included O-alkylation of both ureas and aminolysis to form diguanidine 24, which was subjected to the MOM deprotection to give 25 in 54% yield over two steps. Ozonolysis of the C12 alkene in 25 afforded 26 in 87% yield. Notably, the crude product of 24 could alternatively undergo one-pot ozonolysis/MOM-deprotection to directly provide 26.
However, the 13C NMR analysis of compound 26 indicated that the C12 carbonyl group remained unhydrated. A comparable observation was recently been reported by Looper and co-workers, who conducted a detailed computational investigation on the hydration propensity of the C12 carbonyl group. Their results suggested that the conformation of the C4–C12 bond plays a critical role: compounds adopting a staggered arrangement of the C4 and C12 substituents readily undergo hydration, whereas those with an eclipsed conformation are less susceptible. To evaluate the conformation of 26, we performed density functional theory (DFT) calculations to refine its geometry: interestingly, in the absence of macrocyclic constrains, 26 adopted a staggered C4–C12 alignment (Figure S2; see Supporting Information for details). We thus hypothesize that the presence of the additional cis-fused five-membered ring hinders the approach of water molecules needed to stabilize the hydrated form. As a result, compound 26 preferentially remains in its carbonyl form, whereas dc-STX (1b) more readily exists in the hydrated state.
The NaV-inhibitory activity of analogs 25 and 26 were evaluated using whole-cell patch-clamp recording in CHO cells expressing human NaV1.4 (Figures S3 and S4), as STX is known to exhibit approximately 250-fold greater potency against NaV1.4 compared to NaV1.7. , The IC25 values of analogue 25 were found to be >30 μM and 19 μM in the resting and half-inactivated states, respectively (Figure ). Analog 26 exhibited IC25 values of 7.9 μM for the resting state and 1.3 μM for the half-inactivated state. For comparison, synthetic (±)-dcSTX (1b) was used as a control, displaying significantly higher potency, with IC25 values of 0.049 μM in the resting state and 0.014 μM in the half-inactivated state.
4.
Bioactivity of racemic dc-STX (1b), 25, and 26.
In summary, we have designed a novel analogue of dc-STX and completed its racemic synthesis in 16 steps. A key feature of this route was the development of a photoinduced cycloaddition that simultaneously constructed the fused core and adjacent quaternary carbon centers. Subsequent transformations, including ozonolysis and Ti(III)-mediated radical cyclization, enabled completion of the synthesis. Although the final compound (26) exhibited significantly lower potency compared to racemic dc-saxitoxin (1b), this study expands the structure–activity relationship understanding of saxitoxin and establishes a new synthetic platform for its future modification.
Supplementary Material
Acknowledgments
This work was supported by the National Natural Science Foundation of China (Grants 22425101 and 22171011), College of Chemistry and Molecular Engineering, Peking University, Beijing National Laboratory for Molecular Sciences, Peking-Tsinghua Center for Life Sciences, and Shenzhen Bay Laboratory. We thank Prof. Xiaoguang Lei (Peking University) for help with LC-MS. The measurements of NMR, mass spectrometry, and XRD were performed at the Analytical Instrumentation Center of Peking University. We acknowledge the assistance and support from PKUAIC and support from the High-Performance Computing Platform of Peking University.
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacsau.5c01028.
Experimental procedures, characterization data, and NMR spectra of all newly synthesized compounds (PDF)
∥.
R. Fang and Y. Jiao contributed equally. CRediT: Runting Fang conceptualization, data curation, formal analysis, investigation, writing - original draft, writing - review & editing; Yang Jiao conceptualization, data curation, formal analysis, investigation, writing - original draft, writing - review & editing; Tianrun Xia conceptualization, data curation, investigation; Jiaqi Liu data curation, investigation; Tuoping Luo conceptualization, formal analysis, funding acquisition, project administration, supervision, writing - original draft, writing - review & editing.
The authors declare no competing financial interest.
References
- Catterall W. A., Goldin A. L., Waxman S. G.. International union of pharmacology. XLVII. nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005;57:397. doi: 10.1124/pr.57.4.4. [DOI] [PubMed] [Google Scholar]
- Voltage Gated Sodium Channels, Handbook of Experimental Pharmacology 221; Reuben, P. C. , Ed.; Springer-Verlag: Berlin, 2014. [Google Scholar]
- Yu F. H., Catterall W. A.. Overview of the voltage-gated sodium channel family. Genome Biol. 2003;4:207. doi: 10.1186/gb-2003-4-3-207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogata N., Ohishi Y.. Molecular diversity of structure and function of the voltage-gated Na+ channels. Jpn. J. Pharmacol. 2002;88:365. doi: 10.1254/jjp.88.365. [DOI] [PubMed] [Google Scholar]
- a Wu Q., Huang J., Fan X., Wang K., Jin X., Huang G., Li J., Pan X., Yan N.. Sturctural mapping of NaV1.7 antagonists. Nat. Commun. 2023;14:3224. doi: 10.1038/s41467-023-38942-3. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Alsaloum M., Higerd G. P., Effraim P. R., Waxman S. G.. Status of peripheral sodium channel blockers for non-addictive pain treatment. Nat. Rev. Neurol. 2020;16:689. doi: 10.1038/s41582-020-00415-2. [DOI] [PubMed] [Google Scholar]; c Johnson M. R., Kaminski R. M.. A systems-level framework for anti-epilepsy drug discovery. Neuropharmacology. 2020;170:107868. doi: 10.1016/j.neuropharm.2019.107868. [DOI] [PubMed] [Google Scholar]
- a Mulcahy J. V., Pajouhesh H., Beckley J. T., Delwig A., Du Bois J., Hunter J. C.. Challenges and opportunities for therapeutics targeting the voltage-gated sodium channel isoform NaV 1.7. J. Med. Chem. 2019;62:8695. doi: 10.1021/acs.jmedchem.8b01906. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Noreng S., Li T., Payandeh J.. Structural pharmacology of voltage-gated sodium channels. J. Mol. Bio. 2021;433:166967. doi: 10.1016/j.jmb.2021.166967. [DOI] [PubMed] [Google Scholar]
- McKerrall K. J., Nguyen T., Lai K. W., Bergeron P., Deng L., DiPasquale A., Chang J. H., Chen J., Chernov-Rogan T., Hackos D. H., Maher J., Ortwine D. F., Pang J., Payandeh J., Proctor W. R., Shields S. D., Vogt J., Ji P., Liu W., Ballini E., Schumann L., Tarozzo G., Bankar G., Chowdhury S., Hasan A., Johnson J. P., Khakh K., Lin S., Cohen C. J., Dehnhardt C. M., Safina B. S., Sutherlin D. P.. Structure- and ligand-based discovery of chromane arylsulfonamide NaV 1.7 inhibitors for the treatment of chronic pain. J. Med. Chem. 2019;62:4091. doi: 10.1021/acs.jmedchem.9b00141. [DOI] [PubMed] [Google Scholar]
- Zhang M., Gruszczynski P., Walewska A., Bulaj G., Olivera B. M., Yoshikami D.. Cooccupancy of the outer vestibule of voltage-gated sodium channels by μ-conotoxin KIIIA and saxitoxin or tetrodotoxin. J. Neurophysiol. 2010;104:88. doi: 10.1152/jn.00145.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thottumkara A. P., Parsons W. H., Du Bois J.. Saxitoxin. Angew. Chem., Int. Ed. 2014;53:5760. doi: 10.1002/anie.201308235. [DOI] [PubMed] [Google Scholar]
- Walker J. R., Novick P. A., Parsons W. H., McGregor M., Zablocki J., Pande V. S., Du Bois J.. Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (NaV 1.7) Proc. Natl. Acad. Sci. U.S.A. 2012;109:18102. doi: 10.1073/pnas.1206952109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andresen B. M., Du Bois J.. De novo synthesis of modified saxitoxins for sodium ion channel study. J. Am. Chem. Soc. 2009;131:12524. doi: 10.1021/ja904179f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akimoto T., Masuda A., Yotsu-Yamashita M., Hirokawa T., Nagasawa K.. Synthesis of saxitoxin derivatives bearing guanidine and urea groups at C13 and evaluation of their inhibitory activity on voltage-gated sodium channels. Org. Biomol. Chem. 2013;11:6642. doi: 10.1039/c3ob41398e. [DOI] [PubMed] [Google Scholar]
- Thomas-Tran R., Du Bois J.. Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of hNaV1.7. Proc. Natl. Acad. Sci. U.S.A. 2016;113:5856. doi: 10.1073/pnas.1603486113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adachi K., Yamada T., Ishizuka H., Oki M., Tsunogae S., Shimada N., Chiba O., Orihara T., Hidaka M., Hirokawa T., Odagi M., Konoki K., Yotsu-Yamashita M., Nagasawa K.. Synthesis of C12-keto saxitoxin derivatives with unusual inhibitory activity against voltage-gated sodium channels. Chem.Eur. J. 2020;26:2025. doi: 10.1002/chem.201904184. [DOI] [PubMed] [Google Scholar]
- Pajouhesh H., Beckley J. T., Delwig A., Hajare H. S., Luu G., Monteleone D., Zhou X., Ligutti J., Amagasu S., Moyer B. D., Yeomans D. C., Du Bois J., Mulcahy J. V.. Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins. Sci. Rep. 2020;10:9074. doi: 10.1038/s41598-020-71135-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For a work adding benign complexity to increase the activity of natural products, see:; Allemann O., Brutsch M., Lukesh J. C., Brody D. M., Boger D. L.. Synthesis of a potent vinblastine: rationally designed added benign complexity. J. Am. Chem. Soc. 2016;138:8376. doi: 10.1021/jacs.6b04330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiao Y., Liu J., Mao W., Fang R., Xia T., Lang Q., Luo T.. Synthesis of (+)-saxitoxin facilitated by a chiral auxiliary for photocycloadditions involving alkenylboronate esters. J. Am. Chem. Soc. 2025;147:9091. doi: 10.1021/jacs.5c00666. [DOI] [PubMed] [Google Scholar]
- a Wender P. A., Takahashi H., Witulski B.. Transition metal catalyzed [5 + 2] cycloadditions of vinylcyclopropanes and alkynes: a homolog of the Diels-Alder reaction for the synthesis of seven-membered rings. J. Am. Chem. Soc. 1995;117:4720. doi: 10.1021/ja00121a036. [DOI] [Google Scholar]; b Wender P. A., Rieck H., Fuji M.. The transition metal-catalyzed intermolecular [5 + 2] cycloaddition: the homologous Diels–Alder reaction. J. Am. Chem. Soc. 1998;120:10976. doi: 10.1021/ja982196x. [DOI] [Google Scholar]; c Wender P. A., Barzilay C. M., Dyckman A. J.. The first intermolecular transition metal-catalyzed [5 + 2] cycloadditions with simple, unactivated, vinylcyclopropanes. J. Am. Chem. Soc. 2001;123:179. doi: 10.1021/ja0021159. [DOI] [PubMed] [Google Scholar]; d Wender P. A., Gamber G. G., Scanio M. J. C.. Serial [5 + 2]/[4 + 2] cycloadditions: facile, preparative, multi-component syntheses of polycyclic compounds from simple, readily available starting materials. Angew. Chem., Int. Ed. 2001;40:3895. doi: 10.1002/1521-3773(20011015)40:20<3895::AID-ANIE3895>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]; e Wender P. A., Williams T. J.. [(arene)Rh(cod)]+ complexes as catalysts for [5 + 2] cycloaddition reactions. Angew. Chem., Int. Ed. 2002;41:4550. doi: 10.1002/1521-3773(20021202)41:23<4550::AID-ANIE4550>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]; f Wegner H. A., de Meijere A., Wender P. A.. Transition metal-catalyzed intermolecular [5 + 2] and [5 + 2+1] cycloadditions of allenes and vinylcyclopropanes. J. Am. Chem. Soc. 2005;127:6530. doi: 10.1021/ja043671w. [DOI] [PubMed] [Google Scholar]; g Wender P. A., Haustedt L. O., Lim J., Love J. A., Williams T. J., Yoon J.-Y.. Asymmetric catalysis of the [5 + 2] cycloaddition reaction of vinylcyclopropanes and π-systems. J. Am. Chem. Soc. 2006;128:6302. doi: 10.1021/ja058590u. [DOI] [PubMed] [Google Scholar]; h Liu P., Sirois L. E., Cheong P. H. Y., Yu Z. X., Hartung I. V., Rieck H., Wender P. A., Houk K. N.. Electronic and steric control of regioselectivities in Rh(I)-catalyzed (5 + 2) cycloadditions: experiment and theory. J. Am. Chem. Soc. 2010;132:10127. doi: 10.1021/ja103253d. [DOI] [PubMed] [Google Scholar]; i Wender P. A., Stemmler R. T., Sirois L. E.. A metal-catalyzed intermolecular [5 + 2] cycloaddition/Nazarov cyclization sequence and cascade. J. Am. Chem. Soc. 2010;132:2532. doi: 10.1021/ja910696x. [DOI] [PubMed] [Google Scholar]; j Hong X., Stevens M. C., Liu P., Wender P. A., Houk K. N.. Reactivity and chemoselectivity of allenes in Rh(I)-catalyzed intermolecular (5 + 2) cycloadditions with vinylcyclopropanes: allene-mediated rhodacycle formation can poison Rh(I)-catalyzed cycloadditions. J. Am. Chem. Soc. 2014;136:17273. doi: 10.1021/ja5098308. [DOI] [PMC free article] [PubMed] [Google Scholar]; k Trost B. M., Toste F. D., Shen H.. Ruthenium-catalyzed intramolecular [5 + 2] cycloadditions. J. Am. Chem. Soc. 2000;122:2379. doi: 10.1021/ja993400z. [DOI] [PubMed] [Google Scholar]; l Trost B. M., Toste F. D.. Synthesis of the first (1–3:6,7-η-cyclodecadienyl)ruthenium complex by the intramolecular reaction of an alkene and a vinylcyclopropane. Angew. Chem., Int. Ed. 2001;40:1114. doi: 10.1002/1521-3773(20010316)40:6<1114::AID-ANIE11140>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]; m Trost B. M., Shen H. C.. Constructing tricyclic compounds containing a seven-membered ring by ruthenium-catalyzed intramolecular [5 + 2] cycloaddition. Angew. Chem., Int. Ed. 2001;40:2313. doi: 10.1002/1521-3773(20010618)40:12<2313::AID-ANIE2313>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]; n Zuo G., Louie J.. Selectivity in nickel-catalyzed rearrangements of cyclopropylen-ynes. J. Am. Chem. Soc. 2005;127:5798. doi: 10.1021/ja043253r. [DOI] [PubMed] [Google Scholar]; o Fürstner A., Majima K., Martin R., Krause H., Kattnig E., Goddard R., Lehmann C. W.. A cheap metal for a “noble” task: preparative and mechanistic aspects of cycloisomerization and cycloaddition reactions catalyzed by low-valent iron complexes. J. Am. Chem. Soc. 2008;130:1992. doi: 10.1021/ja0777180. [DOI] [PubMed] [Google Scholar]
- Zhu M., Huang X.-L., Sun S., Zheng C., You S.-L.. Visible-light induced dearomatization of indoles/pyrroles with vinylcyclopropanes: expedient synthesis of structurally diverse polycyclic indolines/pyrrolines. J. Am. Chem. Soc. 2021;143:13441. doi: 10.1021/jacs.1c07082. [DOI] [PubMed] [Google Scholar]
- Singh N., Malik A. H., Iyer P. K., Patra S.. Diversifying the xanthine scaffold for potential phosphodiesterase 9A inhibitors: synthesis and validation. Med. Chem. Res. 2021;30:1199. doi: 10.1007/s00044-021-02722-9. [DOI] [Google Scholar]
- Smaligo A. J., Wu J., Burton N. R., Hacker A. S., Shaikh A. C., Quintana J. C., Wang R., Xie C., Kwon O.. Oxodealkenylative cleavage of alkene C(sp3)-C(sp2) bonds: a practical method for introducing carbonyls into chiral pool materials. Angew. Chem., Int. Ed. 2020;59:1211. doi: 10.1002/anie.201913201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xie H., Guo J., Wang Y., Wang K., Guo P., Su P., Wang X., Shu X.. Radical dehydroxylative alkylation of tertiary alcohols by Ti catalysis. J. Am. Chem. Soc. 2020;142:16787. doi: 10.1021/jacs.0c07492. [DOI] [PubMed] [Google Scholar]
- Li W., Paladugu S. R., Liles J. P., Karthikeyan M., Chase K., Raghuraman S., Sigman M. S., Looper R. E.. Macrocycles of saxitoxin: insights into the structure of zetekitoxin AB. ChemBioChem. 2025;26:e202500170. doi: 10.1002/cbic.202500170. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.